| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |